These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 215175)

  • 21. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
    Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
    Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute effects of cholestyramine on serum lipoprotein concentrations in type II hyperlipoproteinaemia.
    Olsson AG; Dairou F
    Atherosclerosis; 1978 Jan; 29(1):53-61. PubMed ID: 204317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Composition of low-density lipoprotein in children with hyperlipoproteinaemia.
    Bagnall TF; Lloyrd JK
    Clin Chim Acta; 1975 Mar; 59(3):271-6. PubMed ID: 165017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treating lipid disorders.
    Manninen V; Mälkönen M; Tuomilehto J
    Am Heart J; 1979 May; 97(5):674-6. PubMed ID: 219673
    [No Abstract]   [Full Text] [Related]  

  • 26. Correlation between plasma levels of fenofibrate and lipoprotein changes in hyperlipidaemic patients.
    Sirtori CR; Montanari G; Gianfranceschi G; Sirtori M; Galli G; Bosisio E
    Eur J Clin Pharmacol; 1985; 28(6):619-24. PubMed ID: 3840743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic relationships among the plasma lipoproteins. Reciprocal changes in the concentrations of very low and low density lipoproteins in man.
    Wilson DE; Lees RS
    J Clin Invest; 1972 May; 51(5):1051-7. PubMed ID: 4341500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
    Mackness MI; Bhatnagar D; Durrington PN; Prais H; Haynes B; Morgan J; Borthwick L
    Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.
    Carlson K; Carlson LA
    Scand J Clin Lab Invest; 1975 Nov; 35(7):655-60. PubMed ID: 174185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type IV hyperlipoproteinaemia.
    Kwiterovich PO; Margolis S
    Clin Endocrinol Metab; 1973 Mar; 2(1):41-71. PubMed ID: 4359117
    [No Abstract]   [Full Text] [Related]  

  • 31. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG; Lavy A; Aviram M; Zinder O
    Atherosclerosis; 1980 Aug; 36(4):461-9. PubMed ID: 7417365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marked removal of bezafibrate-induced high-density lipoprotein-cholesterol by low-density lipoprotein apheresis.
    Kawano M; Kuroda Y; Terao M; Yaginuma T; Kawakami M; Kanazawa Y
    Clin Chim Acta; 2002 Apr; 318(1-2):91-5. PubMed ID: 11880117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies in asymptomatic primary hyperlipidaemia. IV. ECG at rest and during exercise and its relation to various lipoprotein classes.
    Olsson AG; Ekelund LG; Carlson LA
    Acta Med Scand; 1975; 198(1-2):55-73. PubMed ID: 170796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B; Lithell H; Gustafsson IB; Borberg J
    Atherosclerosis; 1979 Aug; 33(4):457-77. PubMed ID: 228684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.
    Stewart JM; Packard CJ; Lorimer AR; Boag DE; Shepherd J
    Atherosclerosis; 1982 Sep; 44(3):355-65. PubMed ID: 6293516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative studies on the influence of different fibrates on serum lipoproteins in endogenous hyperlipoproteinaemia.
    Kłosiewicz-Latoszek L; Szostak WB
    Eur J Clin Pharmacol; 1991; 40(1):33-41. PubMed ID: 2060543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bezafibrate and delayed action etofibrate in hyperlipidemia].
    Lang PD; Vollmar J
    Dtsch Med Wochenschr; 1983 Feb; 108(8):302-5. PubMed ID: 6825604
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K; Kiessling H
    Artery; 1981; 9(6):456-76. PubMed ID: 7337554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypolipidemic effect of beta, beta'-tetramethyl hexadecanedioic acid (MEDICA 16) in hyperlipidemic JCR:LA-corpulent rats.
    Russell JC; Dolphin PJ; Hameed M; Stewart B; Koeslag DG; Rose-Kahn G; Bar-Tana J
    Arterioscler Thromb; 1991; 11(3):602-9. PubMed ID: 2029500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.